FID now scheduled for mid-2019 by FAR. IMO this may slide...

First 5 Last

Share
Profile

Follow
szaba_the_hut

14,167 Posts.

705

06/04/18

15:52

Post #: 32277346
Share

Originally posted by zacma ↑

Entered many years ago. Mostly paid 2.9 c/s, some a bit less some a bit more. Been sitting on 100% for a long time. It was all about the quick buck. Understood nothing, thought Hartley's Report was conservative etc etc. Learned a lot since. When one lives through the collapse of the POO, one has little choice but to learn not only what the industry is like, but also what the "market" is like. The more I learned the more I wanted to stay. Something called fundamentals seamed to become important.
What most investors are troubled by is the length of time it has taken to get not very FAR. However if one considers that it takes such a long time to finally succeed it's not surprising. One probably should have the guts to trade. I am not good at it and I don't want to. I bought enough shares upfront to make an impact if we succeed. And succeed we will. Be it 15 c/s, 20 c/s, 80 c/s or what ever. No junior oil company has the success FAR had or the foot print FAR has in West Africa. This in itself is worth the wait.
As CN said this week, 1 in 10 wells find oil and 1 in 10 oilfinds lead to production. I think we are doing very well. I suspect FID has to be made before we see a substantial SP increase. This should happen early next year. Not that long to wait. What we will see in the meantime are the detractors of FAR, the hammering of our SP and so on. I don't think we are alone in this. Happens to many companies.
The stars in the firmament are the fundamentals and they are as good as they possibly can get.

Expand

FID now scheduled for mid-2019 by FAR.

IMO this may slide (because WPL cannot go to FID) if arbitration status is still unknown.

FAR Price at posting: 8.0¢ Sentiment: Hold Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Failure to report prompts ASX to impose multiple company suspensions

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

LU7

Strong PFS numbers solidify Lithium Universe's big plans for Québec

IRE

Iress runs 'hot' for Wealth Within's stock tips

There are more pages in this discussion • 11 more messages in this thread...

First 5 Last

Add FAR (ASX) to my watchlist

(20min delay)
Last 46.5¢		Change -0.015(3.13%)		Mkt cap ! $42.97M

Open	High	Low	Value	Volume
46.5¢	46.5¢	46.5¢	$3.174K	6.826K

Buyers (Bids)

No.	Vol.	Price($)
2	53774	46.5¢

Sellers (Offers)

Price($)	Vol.	No.
47.0¢	2400	1

View Market Depth

No.	Vol.	Price($)
1	43174	0.465
1	50000	0.460
1	50000	0.455
1	1822	0.450
1	3000	0.445

Price($)	Vol.	No.
0.470	2400	1
0.475	50000	1
0.480	50000	1
0.485	54000	2
0.490	4000	1

Last trade - 15.59pm 01/10/2024 (20 minute delay)

FAR (ASX) Chart

FID now scheduled for mid-2019 by FAR. IMO this may slide...

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Failure to report prompts ASX to impose multiple company suspensions

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Iress runs 'hot' for Wealth Within's stock tips

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

FID now scheduled for mid-2019 by FAR. IMO this may slide...

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Failure to report prompts ASX to impose multiple company suspensions

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Iress runs 'hot' for Wealth Within's stock tips

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News